Abstract
The high mobility group (HMG) proteins I and Y are well characterised non-histone chromosomal proteins which bind to A-T rich regions of DNA and regulate gene expression and/or DNA replication. A correlation has been demonstrated between the increased expression of HMG-Y proteins and malignancy. However, it is not known whether the expression of HMGs particularly, the Y group, is a function of proliferation rate. In the present study, we have used normal tissues of calf testes, thymus and liver. The results show distinctly high expression of HMG-Y proteins in testes than in thymus and the expression was practically undetectable in liver. The results suggest that even in normal tissues there is a direct correlation between the proliferation rate and the expression of the HMG-Y proteins, which can partly explain its increased expression in cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bustin, M. Reeves, R. (1996) HMG chromosomal proteins architectural components that facilitate chromatin function. Prog. Nucleic Acid Res.&Mol. Bio. 43, 35–100.
Johns, E.W., 1982 The HMG Chromosomal Proteins Ed. Johns E. W Academic press, London p 1–7.
Zhou, X. and Chada, K. (1998) HMG I family proteins: architectural transcription factors in mammalian development and cancer. Keio J. Med. 47, 73–77.
Liu, W.M., Guerra-Vladusic, F.K. Kurakata, S., Lupu, R. and Kohwi-Shigematsu, T. (1999) HMG-l(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype. Cancer Res. 59, 5695–703.
Reeves, R. and Nissen, M. (1999) Purification and assays for HMG l (Y) protein function In: Methods Enzymology, Eds. Wasserman, P. M. and Woffe, A. P. Academic press, London, 304, 155–188.
Tallini, G., Vanni, R., Manifioletti, G. Kajmierczak, B., Faa, G., Pauwells, P., Bullerdiek, J., Giancotti, V., Berghe, V.D and Dal, C.P. (2000) HMGl-C and HMGl(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGl-C and HMGl(Y) gene. Lab. Invest. 80, 359–69.
Kim, S.J., Ryu, J.W. and Choi, D.S. (2000) The expression of high mobility group l(Y) mRNA in thyroid cancers: useful tool of differential diagnosis of thyroid nodules. Korean J. Intern. Med. 15, 71–75.
Giancotti, V. Bandiera, A., Gian, L., Santoro, D., Grant, R.C., Goodwin, G.H., Biochi, M., Dolcetti, R., and Casetta, B. (1993) High mobility group (HMG) proteins and histone H1, subtypes expression in normal and tumour tissues of mouse. Eur. J. Biochem. 213,825–832.
Giancotti, V., Buratti, E., Perissin, L., Zorzet, S., Balmain, A., Portella, G., Fusco, A. and Goodwin, G. H. (1989) Analysis of HMG l nuclear proteins in mouse neoplastic cells induced by different procedures. Exp. Cell. Res. 184, 538–545.
Chiapetta, G., Berlingieri, M.T., Manfioletti, G., Santora M., Bandiera, A., Visconti, R., Giancotti, V. and Fusco A. (1995) The expression of HMGl(Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene. 10, 1307–1314.
Fedele, M., Bandiera, A., Chiapetta, G., Battista, S., Vigiletto., M.G., Casamassiumi, A., Santoro, M., Giancotti, V. and Fusco, A. (1996) Human colorectal carcinomas express high levels of high mobility group HMGl(Y) proteins. Cancer Res. 56, 1846–1901.
Bandiera, A., Bonifacia, D., Zanconati, F., Manfioletti, F., Rustighi, A., Fusco, A., Bonito, L.D., Giancotti, V. (1998) Expression of HMGl(Y) proteins in squamous intra-epithelial and invasive lesion of the uterine cervix. Cancer Res. 58, 426–431.
Tallini, G., Dalcin, P., Rhoden, K.J., Chiapetta, G., Giancotti, V. and Fusco, A. (1997). Expression of HMGl (Y) and HMGl (Y) in ordinary lipomas and atypical lipomatous tumours: immunohistochemical reactivity correlates with karyotypic alteraction. Amer. J. Pathol. 151, 37–43.
Scala, S., Portella, G., Fedele, M., Chiapetta, G. and Fusco, A. (2000) Adenovirus mediated suppression of HMG l(Y) protein synthesis as potential therapy of human malignant neoplasias. Proc. Natl. Acad. Sci. USA. 97, 4256–4261.
Singh, D. and Rajeswari, M. R. (1999) High mobility group chromosomal, proteins: Expression in skin carcinoma in rats; J. Biosci. 24, Suppl. p106.
Goodwin, G. H., Nicholas, R. H. and Johns, E. W. (1975) An improved large-scale fractionation of high mobility group non-histone chromatin, protein. Biochim Biophys Acta. 405, 280–91.
Elgin, S. C. and Bonner, J. (1972) Partial fractionation, and chemical characterisation of the major nonhistone chromosomal proteins. Biochemistry 11, 772–781.
Lowry, O. H., Rosebrough, N.J., Farr, A. L. and Randall, R. J. (1951) Protein measurement with Folin phenol reagent J. Biol. Chem. 193, 265–275.
Elton, T. S. and Reeves, R. (1985) Microheterogeneity of the mammalian high mobility group (HMG) proteins 1 and 2 investigated by reverse phase high performance liquid chromatograph. Anal. Biochem. 144, 403–416.
Bussemakers, M. J. G., Ven, W. J. M. V. D., Debruyne, M. J. and Schalken, J. A. (1991) Idenification of high mobility group protein l(Y) as potential progression marker for prostate cancer. Cancer Res. 51, 606–611.
Thanos, D. and Maniatis, T. (1992) The HMG-l(Y) is raised for NF-KB dependent virus induction of human IFN-B gene. Cell 71, 777–780.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Singh, D., Rajeswari, M.R. Enhanced expression of HMG-Y proteins in proliferating tissues. Indian J Clin Biochem 16, 72–76 (2001). https://doi.org/10.1007/BF02867571
Issue Date:
DOI: https://doi.org/10.1007/BF02867571